As the beauty and personal care world sees a growing interest in premium beauty, Johnson & Johnson’s mass-heavy portfolio is holding steady through its power brands Neutrogena, Aveeno and Listerine. While the company is seeing a slowdown in growth,…
In light of Coronavirus, Johnson & Johnson is expected to perform above industry average in 2020, boosted by the successes of its analgesics and cough, cold and allergy remedies brands. While its OTC portfolio is well positioned to see growth at the…
Johnson & Johnson Inc (J&J) is the second largest company in consumer health. OTC remains its most important category, supported by its global power brands, while its presence in vitamins and dietary supplements (VDS) continues to be limited. The…
Johnson & Johnson (J&J), with its global brand Acuvue, is the market leader in contact lenses. However, competition is fierce, and to maintain its edge J&J will have to continue investing heavily in the fast-growing daily disposables category, and…
J&J Inc.’s consumer division kept a steady growth in 2017. The division’s sales have mainly been stemming from skin care products thanks to strong well-established brands such as Aveeno or Neutrogena. The company’s sales in baby products has been…
With the company’s focus on turning around its US consumer health business, Johnson & Johnson’s tissue and hygiene business appears to have been less of a priority, which may have contributed to the company’s poor performance in its domestic market.…